![Kendall Mohler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kendall Mohler
Corporate Officer/Principal chez ALSP ORCHID ACQUISITION CORPORATION I
Postes actifs de Kendall Mohler
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALSP ORCHID ACQUISITION CORPORATION I | Corporate Officer/Principal | - | - |
Accelerator Services Corp
![]() Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Corporate Officer/Principal | 01/10/2017 | - |
Neuvogen, Inc. | Directeur/Membre du Conseil | - | - |
Emergent Product Development Seattle
![]() Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Private Equity Investor | - | - |
Corporate Officer/Principal | - | - |
Historique de carrière de Kendall Mohler
Anciens postes connus de Kendall Mohler
Sociétés | Poste | Début | Fin |
---|---|---|---|
JUNO THERAPEUTICS INC | Directeur Technique/Scientifique/R&D | 01/10/2013 | 01/04/2017 |
Immunex Corp.
![]() Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Corporate Officer/Principal | 01/01/2001 | 01/01/2002 |
ZetaRx Biosciences, Inc.
![]() ZetaRx Biosciences, Inc. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., ZetaRx Biosciences, Inc. is a company that develops therapies for the treatment of cancers and other diseases. The company is based in Seattle, WA. The company was founded by Jack Kavanaugh. ZetaRx Biosciences was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on October 31, 2013 for $8.40 million. | Directeur Technique/Scientifique/R&D | - | - |
Emergent Product Development Seattle
![]() Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Directeur Technique/Scientifique/R&D | 01/03/1999 | - |
Fondateur | 17/11/2009 | - |
Formation de Kendall Mohler
University of Kansas | Undergraduate Degree |
The University of Texas at Austin | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Îles Cayman | 2 |
Opérationnelle
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Founder | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Finance | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 7 |
---|---|
Emergent Product Development Seattle
![]() Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
Immunex Corp.
![]() Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Juno Therapeutics, Inc.
![]() Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
ZetaRx Biosciences, Inc.
![]() ZetaRx Biosciences, Inc. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., ZetaRx Biosciences, Inc. is a company that develops therapies for the treatment of cancers and other diseases. The company is based in Seattle, WA. The company was founded by Jack Kavanaugh. ZetaRx Biosciences was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on October 31, 2013 for $8.40 million. | Health Technology |
ALSP Orchid Acquisition Corp. I
![]() ALSP Orchid Acquisition Corp. I Financial ConglomeratesFinance ALSP Orchid Acquisition Corp. I is a blank check company. It was formed for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase or other similar business combination, one or more operating businesses. The company was founded on August 31, 2021 and is headquartered in Seattle, WA. | Finance |
Accelerator Services Corp
![]() Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
Neuvogen, Inc. |
- Bourse
- Insiders
- Kendall Mohler
- Expérience